Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jack

Showing results (351-360 of 1,406) with videos related to

Pageof 141
Sort By:
Alzheimer Disease and Associated Disorders|July 3, 2009
MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study populationRema Raman, Ronald G Thomas, Michael W Weiner, et al.
Pharmacogenomics|January 22, 2014
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell linesChad C Brown, Tammy M Havener, Marisa W Medina, et al.
Neurology|October 22, 1998
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's diseaseC R Jack, R C Petersen, Y Xu, et al.
Journal of Neurology|October 1, 2008
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementiaElisabeth C W van Straaten, Danielle Harvey, Philip Scheltens, et al.
The FEBS Journal|August 8, 2007
Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activityBridie A Kelly, Stuart J Neil, Aine McKnight, et al.
Proceedings. IEEE International Symposium on Biomedical Imaging|June 24, 2014
Alzheimer's Disease Disrupts Rich Club Organization in Brain Connectivity NetworksMadelaine Daianu, Emily L Dennis, Neda Jahanshad, et al.
Journal of the American Heart Association|November 15, 2024
Two-Stage Recruitment Design to Reduce Magnetic Resonance Imaging Screening Cost for a Theoretical Clinical Trial of White Matter Hyperintensity ProgressionMarco Egle, Mohini Johri, Melinda C Power, et al.
Neuroimage|December 26, 2009
Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selectionKelvin K Leung, Matthew J Clarkson, Jonathan W Bartlett, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 25, 2011
Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance ImagingKwangsik Nho, Li Shen, Sungeun Kim, et al.
Archives of Neurology|July 15, 2009
Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibshipsStephen T Turner, Myriam Fornage, Clifford R Jack, et al.
Pageof 141

Showing results (351-360 of 1,406) with videos related to

Sort By:
Pageof 141
Alzheimer Disease and Associated Disorders|July 3, 2009
MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study populationRema Raman, Ronald G Thomas, Michael W Weiner, et al.
Pharmacogenomics|January 22, 2014
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell linesChad C Brown, Tammy M Havener, Marisa W Medina, et al.
Neurology|October 22, 1998
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's diseaseC R Jack, R C Petersen, Y Xu, et al.
Journal of Neurology|October 1, 2008
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementiaElisabeth C W van Straaten, Danielle Harvey, Philip Scheltens, et al.
The FEBS Journal|August 8, 2007
Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activityBridie A Kelly, Stuart J Neil, Aine McKnight, et al.
Proceedings. IEEE International Symposium on Biomedical Imaging|June 24, 2014
Alzheimer's Disease Disrupts Rich Club Organization in Brain Connectivity NetworksMadelaine Daianu, Emily L Dennis, Neda Jahanshad, et al.
Journal of the American Heart Association|November 15, 2024
Two-Stage Recruitment Design to Reduce Magnetic Resonance Imaging Screening Cost for a Theoretical Clinical Trial of White Matter Hyperintensity ProgressionMarco Egle, Mohini Johri, Melinda C Power, et al.
Neuroimage|December 26, 2009
Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selectionKelvin K Leung, Matthew J Clarkson, Jonathan W Bartlett, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 25, 2011
Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance ImagingKwangsik Nho, Li Shen, Sungeun Kim, et al.
Archives of Neurology|July 15, 2009
Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibshipsStephen T Turner, Myriam Fornage, Clifford R Jack, et al.
Pageof 141